Galaxy Surfactants (GALAXYSURF) Q4 25/26 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 25/26 earnings summary
8 Sep, 2026Executive summary
Q4 and FY 2026 performance remained resilient despite significant disruptions from the West Asia conflict, impacting global supply chains, logistics, and input costs.
India volumes grew by high single digits in Q4, led by Specialty Care Products and non-Tier 1 segments, while AMET and Rest of World regions faced volume declines due to logistics and raw material constraints.
Americas showed sequential improvement, especially in Specialty Care Products, following tariff reversals.
Audited standalone and consolidated financial results for FY 2025-26 were approved, with unmodified audit opinions from statutory auditors.
A final dividend of ₹22 per equity share was recommended for FY 2025-26, subject to AGM approval.
Financial highlights
Q4 FY 2026 consolidated revenue was ₹1,315 crore, up 14.1% YoY; FY 2026 consolidated revenue was ₹5,270.38 crore, up from ₹4,249.48 crore.
Q4 FY 2026 EBITDA was ₹122 crore, down from ₹135 crore in Q4 FY 2025; FY 2026 EBITDA was ₹497 crore, down 2.5% YoY.
Q4 FY 2026 PAT was ₹62 crore, down 17.7% YoY; FY 2026 PAT was ₹267.38 crore, down from ₹304.91 crore.
Q4 FY 2026 EBITDA per metric ton was ₹20,114; FY 2026 EBITDA per metric ton stood at ₹19,357.
Q4 FY 2026 EPS was ₹17.60 (not annualized); FY 2026 consolidated EPS was ₹75.41.
Outlook and guidance
Q1 FY 2027 is expected to deliver at the higher end of 6%-8% volume growth and EBITDA per metric ton of ₹19,000–21,000, assuming current conditions persist.
Management expects sequential improvement in coming quarters, supported by agile pricing, strong customer partnerships, and focus on specialty growth.
India is expected to maintain 8%-10% growth if demand remains robust and inflationary pressures do not escalate.
Management remains cautious about providing full-year guidance due to ongoing geopolitical and supply chain uncertainties.
The company continues to monitor regulatory developments, especially regarding new labour codes, and will assess accounting implications as further guidance emerges.
Latest events from Galaxy Surfactants
- 8% volume growth and ₹79.72 Cr net profit, with new EU subsidiary and supply chain challenges.GALAXYSURF
Q1 24/25 - ROW and Specialty Care drove growth as margins held firm amid supply chain and price volatility.GALAXYSURF
Q2 24/25 - Q3 volumes fell 1% YoY, margins declined, but international growth and recovery outlook remain.GALAXYSURF
Q3 24/25 - FY25 revenue up 11% with strong ROW growth, margin pressure from input costs, and cautious FY26 outlook.GALAXYSURF
Q4 24/25 - Volumes and revenue rose, but margins narrowed amid input cost and legal risks.GALAXYSURF
Q1 25/26 - Revenue up 24.8% YoY, but margins declined amid higher feedstock costs and tariff headwinds.GALAXYSURF
Q2 25/26 - Q3FY26 revenue up 28% YoY, EBITDA up 13%, PAT down 8.8% due to one-time Labour Code expense.GALAXYSURF
Q3 25/26 - Quarterly EBITDA hit INR 252.5 crores, with strong revenue, profit growth, and upgraded guidance.GALAXYSURF
Q1 26/27